PRIMAQUINE SANOFI 15 mg, film-coated tablet 14 tablets
Active ingredients: Primaquine phosphate, PRIMAQUINE
Commercialized according to BDPMDispensing in France: Prescription only
Tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PRIMAQUINE SANOFI 15 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 14 comprimés reconditionnés
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Feb 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62907143CIP73029322CIP133400930293225Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE DE PRIMAQUINEcomprimé | 26,30 mg · un comprimé | SA |
| PRIMAQUINEcomprimé | 15 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.